1-6 of 6
Kabir Mohammed
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Value of Follow-up Following Complete Remission with Frontline Chemotherapy for DLBCL

Free
Sarah Thompson, Tasneem Elnafie, Tatiana Elwes, Wilam Alfred, Alinane Munyenyembe, Kabir Mohammed, Bhupinder Sharma, MBBS, BSc(Hons) BM FRCR, Ian Chau, MD, David Cunningham, MD FRCP, FMedSci, Sunil Iyengar, MD FRCPath, PhD, Dima El-Sharkawi
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-141982
Published: 2020
Journal Articles

Targeted Next Generation Sequencing Improves Diagnosis in Unclassifiable Leukemic Indolent B-Cell Non-Hodgkin Lymphoma and Identifies a Subset with Recurrent MYD88 Mutations in a Prospective Multicentre Study

Free
Matthew J Cross, MBBS, BSc, Grzegorz Pietka, PhD, Sarah Dunne, Leonora Conneely, Michael Hubank, PhD, Corinne De Lord, MD FRCPath, Michelle Furtado, MD FRCPath, PhD, Pawel Kaczmarek, MD PhD, Dima El-Sharkawi, Claire E. Dearden, MD FRCP, FRCPath, Kabir Mohammed, Alan Stewart Dunlop, MSc, BS, Ricardo Morilla, Karol Pal, PhD, Nikos Darzentas, PhD, David Gonzalez, PhD, Dorte Wren, PhDFRCPath, Sunil Iyengar, MD FRCPath, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-141542
Published: 2020
Journal Articles

Focal Splenic Lesions May Identify Patients Who Benefit from Anthracycline Based Therapy and Are Significantly Associated with High Grade Transformation in Follicular Lymphoma

Free
Charlotte Wilding, BSc, MBChB, Farheen Mir, MBBS, Indu Mitra, Bhupinder Sharma, Larissa Sena, Andrew Wotherspoon, David Cunningham, MD FRCP, Ian Chau, MD, Claire E. Dearden, MD FRCP, FRCPath, Kabir Mohammed, Sunil Iyengar
Journal: Blood
Blood (2017) 130 (Supplement 1): 2786.
https://doi.org/10.1182/blood.V130.Suppl_1.2786.2786
Published: 2017
Journal Articles

Successful Long-Term Outcomes in Patients with Lymphoma Achieving Only Partial Response on [ 18 f]FDG-PET Prior to Allogeneic Transplant

Free
Robert N Lown, MBBS, MDRes), MRCP, FRCPath, Anastasia Constantinidou, Caroline Ebdon, Kabir Mohammed, Mark Ethell, MD, Ian Chau, MD, David Cunningham, FMedSci, Michael Potter, PhD, Bhupinder Sharma, MD
Journal: Blood
Blood (2014) 124 (21): 1249.
https://doi.org/10.1182/blood.V124.21.1249.1249
Published: 2014
Journal Articles

Residual Disease on FDG-PET and Multiple Lines of Prior Therapy Predict Poorer Outcomes Following Autologous Hematopoietic Stem Cell Transplantation for Lymphoma

Free
Robert N Lown, MBBS, MDRes), MRCP, FRCPath, Anastasia Constantinidou, Caroline Ebdon, Kabir Mohammed, Mark Ethell, MD, Ian Chau, MD, David Cunningham, FMedSci, Michael Potter, PhD, Bhupinder Sharma, MD
Journal: Blood
Blood (2014) 124 (21): 3971.
https://doi.org/10.1182/blood.V124.21.3971.3971
Published: 2014
Journal Articles

The Introduction of Novel Agents Improves Outcomes of Young Patients with Myeloma (MM) Treated with Autologous Stem Cell Transplant (ASCT)

Free
Radovan Saso, MD, MPhil, PhD, Kevin D Boyd, MB.BS, Kabir Mohammed, Ping Wu, Jennifer Treleaven, Faith E. Davies, MD, Gareth J Morgan, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1348.
https://doi.org/10.1182/blood.V116.21.1348.1348
Published: 2010